Dan Xu

433 total citations
43 papers, 264 citations indexed

About

Dan Xu is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Dan Xu has authored 43 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 17 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Dan Xu's work include Acute Myeloid Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Dan Xu is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Dan Xu collaborates with scholars based in China, United States and Greece. Dan Xu's co-authors include Fan‐Yi Meng, Qifa Liu, Jing Sun, Zhiping Fan, Hongsheng Zhou, Guopan Yu, Yongqiang Wei, Qianli Jiang, Min Dai and Fen Huang and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Dan Xu

42 papers receiving 259 citations

Peers

Dan Xu
Comparison fields: 5 of 47
  • Hematology 168
  • Genetics 73
  • Public Health, Environmental and Occupational Health 56
  • Oncology 45
  • Rheumatology 43
Alessandra Cupri Italy
Senaka Peter United States
D Bošković Serbia
Mariarita Sciumé Italy
Ambra Di Veroli Italy
Angela Rago Italy
Michelle Cummins United Kingdom
Dubravka Sertić Croatia
Gail Abrahamson United Kingdom
Gianna Maria D’Elia Italy
Alessandra Cupri Italy View profile →
Citations per field, relative to Dan Xu
Dan Xu · 1×
Citations per year, relative to Dan Xu
Dan Xu · 1×

Countries citing papers authored by Dan Xu

Since Specialization
Citations

This map shows the geographic impact of Dan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Xu more than expected).

Fields of papers citing papers by Dan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Xu. The network helps show where Dan Xu may publish in the future.

Co-authorship network of co-authors of Dan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Xu. A scholar is included among the top collaborators of Dan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Xu. Dan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 MiR-365-3p inhibits lung cancer proliferation and migration via CPT1A-mediated fatty acid oxidation Scientific Reports Dan Xu, Bingya Liu et al. 2
2 The sentinel against brain injury post-subarachnoid hemorrhage: efferocytosis of erythrocytes by leptomeningeal lymphatic endothelial cells Theranostics Yan Xu, Kun Wu et al. 4
3 The Efficacy and Safety of CLAG±Ida/Mito+Ven As Salvage Therapy of Relapsed/Refractory Acute Myeloid Leukemia Blood Guopan Yu, Yu Zhang et al. 1
4 Identifying prognostic biomarker related to immune infiltration in acute myeloid leukemia Clinical and Experimental Medicine Weixiang Lu, Guopan Yu et al. 0
5 Selective elimination of CML stem/progenitor cells by picropodophyllin in vitro and in vivo is associated with p53 activation Biochemical and Biophysical Research Communications Yongheng Chen, Qingqing Wu et al. 2
6 A new pre-emptive TKIs strategy for preventing relapse based on BCR/ABL monitoring for Ph+ALL undergoing allo-HCT: a prospective clinical cohort study Leukemia Hui Liu, Li Xuan et al. 12
7 [Analysis of gene mutations and clinic features in 108 patients with myeloproliferative neoplasm]. PubMed Ning Xu, Jingyue Huang et al. 1
8 Gene mutation profile and risk stratification in AML1‑ETO‑positive acute myeloid leukemia based on next‑generation sequencing Oncology Reports Guopan Yu, Changxin Yin et al. 14
9 Influence of FLT3-ITD Mutation and Length on the Prognosis in Acute Myeloid Leukemia Blood Xuejie Jiang, Changxin Yin et al. 1
10 Association between the concentration of imatinib in bone marrow mononuclear cells, mutation status of ABCB1 and therapeutic response in patients with chronic myelogenous leukemia Experimental and Therapeutic Medicine Weiwei Chen, Zhixiang Wang et al. 6
11 Hyperhomocysteinemia is an independent risk factor in young patients with coronary artery disease in southern China Herz Yuli Huang, Guohui Fan et al. 28
12 Correlation between Imatinib Trough Concentration and Efficacy in Chinese Chronic Myelocytic Leukemia Patients Acta Haematologica Fan‐Yi Meng, Dan Xu et al. 23
13 Effect of Antithymocyte Globulin Dosage for Prophylactic Gvhd On Epstein-Barr Virus Reactivation and Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Blood Guopan Yu, Qifa Liu et al. 2
14 Peripheral blood stem cell transplantation compared with bone marrow transplantation from unrelated donors in patients with leukemia: A single institutional experience Blood Cells Molecules and Diseases Yujie Zhang, Jing Sun et al. 7
15 Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China Annals of Hematology Qifa Liu, Xiaojun Xu et al. 14
16 Autologous peripheral hematopoietic stem-cell transplantation in a patient with refractory pemphigus Frontiers of Medicine in China Ledong Sun, Jing Sun et al. 1
17 Association Between Acute Graft Versus Host Disease and Lung Injury after Allogenic Hematopoietic Stem Cell Transplantation Blood Qifa Liu, Xiaodan Luo et al. 1
18 [Role of vascular endothelial growth factor (VEGF) in development and progress of refractory acute myeloid leukemia]. PubMed Dan Xu, Fan‐Yi Meng et al. 4
19 [Expression of vascular endothelial growth factor in bone marrow cells of patients with acute myeloid leukemia]. PubMed Dan Xu, Fan‐Yi Meng et al. 2
20 The ascending branch of the lateral circumflex femoral artery Surgical and Radiologic Anatomy Dan Xu, Jiming Kong et al. 12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026